{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:21:20Z","timestamp":1793683280964,"version":"4.5.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["474777\/2013-8"],"award-info":[{"award-number":["474777\/2013-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["APQ-0814-4.03\/17"],"award-info":[{"award-number":["APQ-0814-4.03\/17"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s42770-023-01071-6","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T12:02:40Z","timestamp":1691150560000},"page":"1513-1521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and non-toxicity of ciclopirox olamine-loaded liposomes against Cryptococcus neoformans clinical isolates"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4088-4690","authenticated-orcid":false,"given":"Patr\u00edcia","family":"de Oliveira Kocerginsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8264-5256","authenticated-orcid":false,"given":"Pedro Henrique","family":"dos Santos Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-3869","authenticated-orcid":false,"given":"Hannah Ferreira Soares","family":"Lyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5872","authenticated-orcid":false,"given":"Pabyton Gon\u00e7alves","family":"Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8846-877X","authenticated-orcid":false,"given":"Reginaldo Gon\u00e7alves","family":"de Lima-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-9096","authenticated-orcid":false,"given":"Nicodemos Teles","family":"Pontes-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-8042","authenticated-orcid":false,"given":"Jos\u00e9 Vitor Moreira","family":"Lima-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-3284","authenticated-orcid":false,"given":"S\u00e9rgio Dias","family":"Costa-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4184-7366","authenticated-orcid":false,"given":"Rejane Pereira","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-3502","authenticated-orcid":false,"given":"Isabella Mac\u00e1rio Ferro","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-4213","authenticated-orcid":false,"given":"Nereide Stela","family":"Santos-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"issue":"5","key":"1071_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11046-021-00577-7","volume":"186","author":"EC Francisco","year":"2021","unstructured":"Francisco EC, de Jong AW, Hagen F (2021) Cryptococcosis and cryptococcus. Mycopathologia 186(5):729\u2013731. https:\/\/doi.org\/10.1007\/s11046-021-00577-7","journal-title":"Mycopathologia"},{"key":"1071_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","volume":"78","author":"F Hagen","year":"2015","unstructured":"Hagen F, Khayhan K, Theelen B et al (2015) Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex. Fungal Genet Biol 78:16\u201348. https:\/\/doi.org\/10.1016\/j.fgb.2015.02.009","journal-title":"Fungal Genet Biol"},{"key":"1071_CR3","doi-asserted-by":"publisher","first-page":"w14281","DOI":"10.4414\/smw.2016.14281","volume":"146","author":"Y Schmiedel","year":"2016","unstructured":"Schmiedel Y, Zimmerli S (2016) Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly 146:w14281. https:\/\/doi.org\/10.4414\/smw.2016.14281","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"1071_CR4","doi-asserted-by":"publisher","first-page":"e0011140","DOI":"10.1371\/journal.pntd.0011140","volume":"17","author":"KC Dantas","year":"2023","unstructured":"Dantas KC, de Freitas\u2014Xavier RS, Lombardi SCFS et al (2023) Comparative analysis of diagnostic methods for the detection of Cryptococcus neoformans meningitis. PLoS Neglected Tropical Dis 17(3):e0011140. https:\/\/doi.org\/10.1371\/journal.pntd.0011140","journal-title":"PLOS Neglected Tropical Dis"},{"issue":"11","key":"1071_CR5","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/jac\/dkt221","volume":"68","author":"A Loyse","year":"2013","unstructured":"Loyse A, Dromer F, Day J, Lortholary O, Harrison TS (2013) Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. J Antimicrob Chemother 68(11):2435\u20132444. https:\/\/doi.org\/10.1093\/jac\/dkt221","journal-title":"J Antimicrob Chemother"},{"key":"1071_CR6","unstructured":"World Health Organization (2017) Integrating neglected tropical diseases into global health and development: fourth WHO Report on neglected tropical diseases. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/255011. Accessed 13 Apr 2023"},{"issue":"3","key":"1071_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ejpb.2011.12.001","volume":"80","author":"L Nogueiras-Nieto","year":"2012","unstructured":"Nogueiras-Nieto L, Sobarzo-S\u00e1nchez E, G\u00f3mez-Amoza JL, Otero-Espinar FJ (2012) Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery. Eur J Pharm Biopharm 80(3):585\u2013595. https:\/\/doi.org\/10.1016\/j.ejpb.2011.12.001","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1071_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/ph16010113","volume":"16","author":"X Wan","year":"2023","unstructured":"Wan X, Xiang J, Fan H et al (2023) Ciclopirox olamine induces proliferation inhibition and protective autophagy in hepatocellular carcinoma. Pharmaceuticals (Basel) 16(1):113. https:\/\/doi.org\/10.3390\/ph16010113","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"1071_CR9","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1021\/acsomega.1c00273","volume":"6","author":"J Lin","year":"2021","unstructured":"Lin J, Zangi M, Kumar TVNH et al (2021) Synthetic derivatives of ciclopirox are effective inhibitors of cryptococcus neoformans. ACS Omega 6(12):8477\u20138487. https:\/\/doi.org\/10.1021\/acsomega.1c00273","journal-title":"ACS Omega"},{"issue":"5","key":"1071_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1472-765X.2010.02914.x","volume":"51","author":"PC Oliveira","year":"2010","unstructured":"Oliveira PC, Medeiros CSQ, Mac\u00eado DPC et al (2010) Ciclopirox olamine: an antifungal alternative against cryptococcosis: Ciclopirox olamine: against cryptococcosis. Lett Appl Microbiol 51(5):485\u2013489. https:\/\/doi.org\/10.1111\/j.1472-765X.2010.02914.x","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"1071_CR11","doi-asserted-by":"publisher","first-page":"e00203","DOI":"10.1590\/s2175-97902018000200203","volume":"54","author":"IMF Cavalcanti","year":"2018","unstructured":"Cavalcanti IMF, Menezes TGC, de Campos LAA et al (2018) Interaction study between vancomycin and liposomes containing natural compounds against methicillin-resistant Staphylococcus aureus clinical isolates. Braz J Pharm Sci 54(2):e00203\u2013e00203. https:\/\/doi.org\/10.1590\/s2175-97902018000200203","journal-title":"Braz J Pharm Sci"},{"key":"1071_CR12","doi-asserted-by":"publisher","first-page":"122754","DOI":"10.1016\/j.ijpharm.2023.122754","volume":"635","author":"LAA Campos","year":"2023","unstructured":"Campos LAA, Francisco Silva Neto A, Cec\u00edlia Souza Noronha M, Ferreira de Lima M, Mac\u00e1rio Ferro Cavalcanti I, Stela Santos-Magalh\u00e3es N (2023) Zein nanoparticles for drug delivery: preparation methods and biological applications. Int J Pharm 635:122754. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122754","journal-title":"Int J Pharm"},{"issue":"3","key":"1071_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/1120009X.2017.1306183","volume":"29","author":"F Aversa","year":"2017","unstructured":"Aversa F, Busca A, Candoni A et al (2017) Liposomal amphotericin B (Ambisome\u00ae) at beginning of its third decade of clinical use. J Chemother 29(3):131\u2013143. https:\/\/doi.org\/10.1080\/1120009X.2017.1306183","journal-title":"J Chemother"},{"issue":"1","key":"1071_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/21691401.2014.953633","volume":"44","author":"H Daraee","year":"2016","unstructured":"Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A (2016) Application of liposomes in medicine and drug delivery. Artif Cells Nanomedicine Biotechnol 44(1):381\u2013391. https:\/\/doi.org\/10.3109\/21691401.2014.953633","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"issue":"2","key":"1071_CR15","first-page":"1","volume":"1","author":"AM Verma","year":"2010","unstructured":"Verma AM, Palani S (2010) Development and in-vitro evaluation of liposomal gel of ciclopirox olamine. Int J Pharma Bio Sci 1(2):1\u20136","journal-title":"Int J Pharma Bio Sci"},{"issue":"1","key":"1071_CR16","first-page":"360","volume":"2","author":"K Girhepunje","year":"2010","unstructured":"Girhepunje K, Pal R, Gevariya H, Behera A, Thirumoorthy N (2010) Ethosomes: a novel vesicular carrier for enhanced dermal delivery of ciclopiroxolamine. Der Pharm Lett 2(1):360\u2013367","journal-title":"Der Pharm Lett"},{"issue":"7","key":"1071_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/13693780600810040","volume":"44","author":"J Capilla","year":"2006","unstructured":"Capilla J, Maffei CML, Clemons KV, Sobel RA, Stevens DA (2006) Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice. Med Mycol 44(7):601\u2013610. https:\/\/doi.org\/10.1080\/13693780600810040","journal-title":"Med Mycol"},{"issue":"2","key":"1071_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/mmy\/myw056","volume":"55","author":"ACL Fontes","year":"2017","unstructured":"Fontes ACL, Bretas Oliveira D, Santos JRA et al (2017) A subdose of fluconazole alters the virulence of Cryptococcus gattii during murine cryptococcosis and modulates type I interferon expression. Med Mycol 55(2):203\u2013212. https:\/\/doi.org\/10.1093\/mmy\/myw056","journal-title":"Med Mycol"},{"issue":"2","key":"1071_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbamem.2012.10.022","volume":"1828","author":"PG Cadena","year":"2013","unstructured":"Cadena PG, Pereira MA, Cordeiro RBS et al (2013) Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta 1828(2):309\u2013316. https:\/\/doi.org\/10.1016\/j.bbamem.2012.10.022","journal-title":"Biochim Biophys Acta"},{"key":"1071_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.resp.2016.06.001","volume":"231","author":"AM Galv\u00e3o","year":"2016","unstructured":"Galv\u00e3o AM, Galv\u00e3o JS, Pereira MA et al (2016) Cationic liposomes containing antioxidants reduces pulmonary injury in experimental model of sepsis: liposomes antioxidants reduces pulmonary damage. Respir Physiol Neurobiol 231:55\u201362. https:\/\/doi.org\/10.1016\/j.resp.2016.06.001","journal-title":"Respir Physiol Neurobiol"},{"key":"1071_CR21","unstructured":"Hoog GS de, Guarro J, Gen\u00e9 J, Figueras MJ, Botter A (2000) Atlas of clinical fungi, 2nd edn. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands"},{"key":"1071_CR22","unstructured":"Clinical and Laboratory Standards Institute (2020) M60Ed2. Performance Standards for Antifungal Susceptibility Testing of Yeasts, 2nd ed.; CLSI Supplement M60; Clinical and Laboratory Standards Institute: Wayne, PA, USA"},{"issue":"1","key":"1071_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jac\/dkn132","volume":"62","author":"JM Torres-Rodr\u00edguez","year":"2008","unstructured":"Torres-Rodr\u00edguez JM, Alvarado-Ram\u00edrez E, Murciano F, Sellart M (2008) MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii. J Antimicrob Chemother 62(1):205\u2013206. https:\/\/doi.org\/10.1093\/jac\/dkn132","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"1071_CR24","doi-asserted-by":"publisher","first-page":"1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the arrive guidelines for reporting animal research. PLoS Biol 8(6):1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412","journal-title":"PLOS Biol"},{"key":"1071_CR25","unstructured":"Baxter JH, Mason MF (1947) Studies of the mechanisms of liver and kidney injury: iv. A comparison of the effects of pyridine and methyl pyridinium chloride in the rat. J Pharmacol Exp Ther 91(4):350\u2013356. Aspet Journals. https:\/\/jpet.aspetjournals.org\/content\/91\/4\/350. Accessed 13 Apr 2023"},{"key":"1071_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1590\/S0100-879X2010007500012","volume":"43","author":"CS Medeiros","year":"2010","unstructured":"Medeiros CS, Pontes-Filho NT, Camara CA et al (2010) Antifungal activity of the naphthoquinone beta-lapachone against disseminated infection with Cryptococcus neoformans var. neoformans in dexamethasone-immunosuppressed Swiss mice. Braz J Med Biol Res 43:345\u2013349. https:\/\/doi.org\/10.1590\/S0100-879X2010007500012","journal-title":"Braz J Med Biol Res"},{"issue":"11","key":"1071_CR27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10096-013-1915-8","volume":"32","author":"FP Gullo","year":"2013","unstructured":"Gullo FP, Rossi SA, de Sardi CO J, Teodoro VLI, Mendes-Giannini MJS, Fusco-Almeida AM (2013) Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol Infect Dis 32(11):1377\u20131391. https:\/\/doi.org\/10.1007\/s10096-013-1915-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"1071_CR28","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.mycmed.2020.101044","volume":"30","author":"LB Da Silva","year":"2020","unstructured":"Da Silva LB, Bock D, Klafke GB et al (2020) Cryptococcosis in hiv-aids patients from southern brazil: still a major problem. J Mycol Med 30(4):101044. https:\/\/doi.org\/10.1016\/j.mycmed.2020.101044","journal-title":"J Mycol Med"},{"issue":"7","key":"1071_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","volume":"19","author":"KR Iyer","year":"2021","unstructured":"Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE (2021) Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol 19(7):454\u2013466. https:\/\/doi.org\/10.1038\/s41579-021-00511-0","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1071_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0924-8579(02)00021-3","volume":"19","author":"IAJM Bakker-Woudenberg","year":"2002","unstructured":"Bakker-Woudenberg IAJM (2002) Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci. Int J Antimicrob Agents 19(4):299\u2013311. https:\/\/doi.org\/10.1016\/s0924-8579(02)00021-3","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"1071_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1472-765X.2010.02914.x","volume":"51","author":"PC Oliveira","year":"2010","unstructured":"Oliveira PC, Medeiros CSQ, Mac\u00eado DPC et al (2010) Ciclopirox olamine: an antifungal alternative against cryptococcosis. Lett Appl Microbiol 51(5):485\u2013489. https:\/\/doi.org\/10.1111\/j.1472-765X.2010.02914.x","journal-title":"Lett Appl Microbiol"},{"key":"1071_CR32","unstructured":"Shaikh K, Pawar A, Aphale S, Moghe A (2012) Effect of vesicular encapsulation on in-vitro cytotoxicity of ciclopirox olamine. Int J Drug Deliv 4:139\u2013146"},{"issue":"2","key":"1071_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jgar.2015.03.007","volume":"3","author":"IMF Cavalcanti","year":"2015","unstructured":"Cavalcanti IMF, Pontes-Neto JG, Kocerginsky PO et al (2015) Antimicrobial activity of \u03b2-lapachone encapsulated into liposomes against meticillin-resistant Staphylococcus aureus and Cryptococcus neoformans clinical strains. J Glob Antimicrob Resist 3(2):103\u2013108. https:\/\/doi.org\/10.1016\/j.jgar.2015.03.007","journal-title":"J Glob Antimicrob Resist"},{"issue":"11","key":"1071_CR34","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1517\/17425247.2013.822860","volume":"10","author":"M Alhariri","year":"2013","unstructured":"Alhariri M, Azghani A, Omri A (2013) Liposomal antibiotics for the treatment of infectious diseases. Expert Opin Drug Deliv 10(11):1515\u20131532. https:\/\/doi.org\/10.1517\/17425247.2013.822860","journal-title":"Expert Opin Drug Deliv"},{"key":"1071_CR35","doi-asserted-by":"publisher","unstructured":"Nisini R, Poerio N, Mariotti S, De Santis F, Fraziano M (2018) The multirole of liposomes in therapy and prevention of infectious diseases. Front Immunol 2018;9:155.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2018.00155","DOI":"10.3389\/fimmu.2018.00155"},{"issue":"3","key":"1071_CR36","doi-asserted-by":"publisher","first-page":"e00724","DOI":"10.1128\/mBio.00724-19","volume":"10","author":"R Lu","year":"2019","unstructured":"Lu R, Hollingsworth C, Qiu J et al (2019) Efficacy of oral encochleated amphotericin b in a mouse model of cryptococcal meningoencephalitis. mBio 10(3):e00724-19. https:\/\/doi.org\/10.1128\/mBio.00724-19","journal-title":"mBio"},{"key":"1071_CR37","doi-asserted-by":"publisher","unstructured":"Wallace TL, Paetznick V, Cossum PA, Lopez-Berestein G, Rex JH, Anaissie E (1997) Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob Agents Chemother 41(10):2238\u20132243. https:\/\/doi.org\/10.1128\/aac.41.10.2238","DOI":"10.1128\/aac.41.10.2238"},{"issue":"3","key":"1071_CR38","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1128\/AAC.01222-09","volume":"54","author":"RE Lewis","year":"2010","unstructured":"Lewis RE, Albert ND, Liao G, Hou J, Prince RA, Kontoyiannis DP (2010) Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Antimicrob Agents Chemother 54(3):1298\u20131304. https:\/\/doi.org\/10.1128\/AAC.01222-09","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1071_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1365-2710.2010.01172.x","volume":"36","author":"SJ Weir","year":"2011","unstructured":"Weir SJ, Patton L, Castle K, Rajewski L, Kasper J, Schimmer AD (2011) The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy. J Clin Pharm Ther 36(2):128\u2013134. https:\/\/doi.org\/10.1111\/j.1365-2710.2010.01172.x","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"1071_CR40","doi-asserted-by":"publisher","first-page":"10360","DOI":"10.18632\/oncotarget.23164","volume":"9","author":"C Mihailidou","year":"2017","unstructured":"Mihailidou C, Papakotoulas P, Papavassiliou AG, Karamouzis MV (2017) Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget 9(12):10360\u201310374. https:\/\/doi.org\/10.18632\/oncotarget.23164","journal-title":"Oncotarget"},{"key":"1071_CR41","doi-asserted-by":"publisher","first-page":"791916","DOI":"10.3389\/fonc.2022.791916","volume":"12","author":"J Yin","year":"2022","unstructured":"Yin J, Che G, Jiang K et al (2022) Ciclopirox olamine exerts tumor-suppressor effects via topoisomerase ii alpha in lung adenocarcinoma. Front Oncol 12:791916. https:\/\/doi.org\/10.3389\/fonc.2022.791916","journal-title":"Front Oncol"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01071-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-01071-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01071-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T02:21:57Z","timestamp":1694139717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-01071-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-01071-6","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"14 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors approved the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}